246 related articles for article (PubMed ID: 12748254)
41. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
[TBL] [Abstract][Full Text] [Related]
42. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
43. Primary lymphoma of the liver -- morphological and clinical analysis of 6 cases. Success of aggressive treatment.
Ziarkiewicz-Wroblewska B; Gornicka B; Suleiman W; Wroblewski T; Morton M; Wilczynski GM; Heleniak H; Skwarek A; Koperski L; Dudek K; Krawczyk M; Jedrzejczak WW; Dwilewicz-Trojaczek J; Wasiutynski A
Neoplasma; 2005; 52(3):267-72. PubMed ID: 15875091
[TBL] [Abstract][Full Text] [Related]
44. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
Filipits M; Jaeger U; Pohl G; Stranzl T; Simonitsch I; Kaider A; Skrabs C; Pirker R
Clin Cancer Res; 2002 Mar; 8(3):729-33. PubMed ID: 11895902
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of clinical and immunological parameters in diffuse large B-cell lymphomas.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 Apr; (133):96-9. PubMed ID: 16705242
[TBL] [Abstract][Full Text] [Related]
46. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
Bilalovic N; Blystad AK; Golouh R; Nesland JM; Selak I; Trinh D; Torlakovic E
Am J Clin Pathol; 2004 Jan; 121(1):34-42. PubMed ID: 14750238
[TBL] [Abstract][Full Text] [Related]
47. CD10 and Bcl-2 expression combined with the International Prognostic Index can identify subgroups of patients with diffuse large-cell lymphoma with very good or very poor prognoses.
Biasoli I; Morais JC; Scheliga A; Milito CB; Romano S; Land M; Pulcheri W; Spector N
Histopathology; 2005 Mar; 46(3):328-33. PubMed ID: 15720419
[TBL] [Abstract][Full Text] [Related]
48. Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.
Kikuchi A; Nakamura N; Kuze T; Sasaki Y; Abe M; Ohno H; Akasaka T; Nakamura S; Ohshima K; Ando K
Leuk Res; 2008 Aug; 32(8):1176-82. PubMed ID: 18460403
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
50. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics.
Booman M; Douwes J; Glas AM; de Jong D; Schuuring E; Kluin PM
J Pathol; 2006 Oct; 210(2):163-71. PubMed ID: 16823896
[TBL] [Abstract][Full Text] [Related]
51. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
[TBL] [Abstract][Full Text] [Related]
52. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
53. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma.
Sen F; Rassidakis GZ; Jones D; Medeiros LJ
Mod Pathol; 2002 Jun; 15(6):625-31. PubMed ID: 12065776
[TBL] [Abstract][Full Text] [Related]
54. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
[TBL] [Abstract][Full Text] [Related]
55. p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome.
Sáez A; Sánchez E; Sánchez-Beato M; Cruz MA; Chacón I; Muñoz E; Camacho FI; Martínez-Montero JC; Mollejo M; García JF; Piris MA
Br J Cancer; 1999 Jul; 80(9):1427-34. PubMed ID: 10424746
[TBL] [Abstract][Full Text] [Related]
56. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
Rassidakis GZ; Jones D; Lai R; Ramalingam P; Sarris AH; McDonnell TJ; Medeiros LJ
J Pathol; 2003 Jun; 200(2):240-8. PubMed ID: 12754745
[TBL] [Abstract][Full Text] [Related]
57. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associated lymphoid tissue (MALT).
Du M; Singh N; Husseuin A; Isaacson PG; Pan L
J Pathol; 1996 Apr; 178(4):379-84. PubMed ID: 8691314
[TBL] [Abstract][Full Text] [Related]
58. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?
de Leval L; Ferry JA; Falini B; Shipp M; Harris NL
Am J Surg Pathol; 2001 Oct; 25(10):1277-82. PubMed ID: 11688462
[TBL] [Abstract][Full Text] [Related]
59. The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma.
Uherova P; Ross CW; Schnitzer B; Singleton TP; Finn WG
Am J Clin Pathol; 2001 Apr; 115(4):582-8. PubMed ID: 11293907
[TBL] [Abstract][Full Text] [Related]
60. Expressions of the CIP/KIP family of CDK inhibitor proteins in primary intestinal large B-cell lymphomas: correlation with clinical outcomes.
Go JH
Pathol Res Pract; 2002; 198(11):741-6. PubMed ID: 12530577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]